Pulse dose-rate brachytherapy and treatment of uterine cervix cancer: impact of a 3D or a 2D dosimetric support;Curiethérapie utérovaginale de bas débit pulsé : influence du support dosimétrique

Cancer/Radiotherapie

Volumn 11, Issue 4, 2007, Pages 188-196

  Tournat, H ^a   Chilles, A ^b   Charra Brunaud, C ^c   Peiffert, D ^c   Ahmad, F ^c   Metayer Y ^c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b CENTRE LÉON BÉRARD   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

Author keywords

CT scan; Dosimetric support; Pulse dose rate brachytherapy; Standard radiographies

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FOLLOW UP; HUMAN; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RADIATION DOSE; UTERINE CERVIX; UTERINE CERVIX CANCER;

ADULT; AGED; BRACHYTHERAPY; FEMALE; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; UTERINE NEOPLASMS;

EID: 34447331944     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2007.05.004     Document Type: Article

References (27)

1. Bachtiary B., Dewitt A., Pintilie M., Jezioranski J., Ahonen S., Levin W., et al. Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 1077-1082
2. Barillot I., Horiot J.C., Maingon P., Bone-Lepinoy M.C., Vaillant D., and Feutray S. Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother. Oncol. 30 (1994) 231-238
3. Barillot I., and Reynaud-Bougnoux A. The use of MRI in planning radiotherapy for gynaecological tumours. Cancer Imaging 6 (2006) 100-106
4. Bruna A., Gastelblum P., Thomas L., Chapet O., Bollet M.A., Ardiet J.M., et al. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study. Radiother. Oncol. 79 (2006) 75-79
5. Chassagne D., and Horiot J.C. Proposals for common definitions of reference points in gynecological brachytherapy. J. Radiol. Electrol. Med. Nucl. 58 (1977) 371-373
6. Chassagne D., and Pierquin B. Plesiocurietherapy of vaginal cancers by plastic mold with iridium 192 (non-radioactive preparation). J Radiol Electrol Med Nucl. 47 1 (1966) 89-93
7. Creasman W.T. New gynecologic cancer staging. Gynecol Oncol. 58 2 (1995) 157-158
8. Dimopoulos J.C., Schard G., Berger D., Lang S., Goldner G., Helbich T., et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 1380-1388
9. Haie-Meder C., Breton C., de Crevoisier R., and Gerbaulet A. Curietherapy in uterine cervix cancers: what therapeutic trends?. Cancer Radiother. 4 (2000) 133-139
10. Haie-Meder C., and Peiffert D. Innovation in gynaecological brachytherapy: new technologies, pulse dose-rate brachytherapy, image, definition of new volumes of interest and their impact on dosimetry: application in a clinical research programme "STIC". Cancer Radiother. 10 (2006) 402-409
11. Haie-Meder C., Potter R., Van Limbergen E., Briot E., De Brabandere M., Dimopoulos J., et al. Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother. Oncol. 74 (2005) 235-245
12. Houvenaeghel G., Buttarelli M., de Troyer J., Carcopino X., Lelievre L., Tallet A., et al. Surgical resection after chemotherapy for advanced cervical carcinoma. Cancer Radiother. 10 (2006) 471-476
13. International Commission on Radiological Units and Measurements I. Dose and volume specification for reporting intracavitary therapy in gynecology, ICRU Report 38 (1985), ICRU, Bethesda, MD
14. Lahtinen T., Tenhunen M., and Vayrynen M. ICRU reference points and maximum doses of rectum and bladder in intracavitary radiotherapy. Radiother. Oncol. 28 (1993) 174-176
15. Lang S., Nulens A., Briot E., Kirisits C., De Brabandere M., Dumas I., et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN-GEC-ESTRO recommendations. Radiother. Oncol. 78 2 (2006) 185-193
16. Lomax N.J., and Scheib S.G. Quantifying the degree of conformity in radiosurgery treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 1409-1419
17. Muschitz S., Petrow P., Briot E., Petit C., De Crevoisier R., Duvillard P., et al. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Radiother. Oncol. 73 (2004) 187-194
18. Nag S. Controversies and new developments in gynecologic brachytherapy: image-based intracavitary brachytherapy for cervical carcinoma. Semin. Radiat. Oncol. 16 (2006) 164-167
19. Nulens A., Lang S., and Briot E. Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GYN-GEC-ESTRO working group delineation workshops. Radiother. Oncol. 75 (2005) S9
20. Paley P.J., Goff B.A., Minudri R., Greer B.E., Tamimi H.K., and Koh W.J. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. Gynecol. Oncol. 76 (2000) 373-379
21. Peiffert D., Mazeron J.J., Guedea F., and Nisin R. Brachytherapy in France in 2002: results of the ESTRO-PCBE questionnaire. Cancer Radiother. 11 (2007) 146-149
22. Perez C.A., Grigsby P.W., Camel H.M., Galakatos A.E., Mutch D., and Lockett M.A. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a non-randomized comparison. Int. J. Radiat. Oncol. Biol. Phys. 31 4 (1995) 703-716
23. Potter R., Haie-Meder C., Van Limbergen E., Barillot I., De Brabandere M., Dimopoulos J., et al., GEC-ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother. Oncol. 78 1 (2006) 67-77
24. Poupon L., Castelain B., and Lartigau E. Pulse dose rate brachytherapy: optimization and place of imaging. Cancer Radiother. 7 (2003) 136-146
25. Visser A.G., and Symonds R.P. Dose and volume specification for reporting gynaecological brachytherapy: time for a change. Radiother. Oncol. 58 (2001) 1-4
26. Wachter-Gerstner N., Wachter S., Reinstadler E., Fellner C., Knocke T.H., and Potter R. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother. Oncol. 68 1 (2003) 51-59
27. Wachter-Gerstner N., Wachter S., Reinstadler E., Fellner C., Knocke T.H., and Wambersie A. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother. Oncol. 68 (2003) 269-276